Clinical trials
Observational Atherosclerosis trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 5 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| University Hospital, Grenoble | 3 |
| Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | 2 |
| University Hospital, Toulouse | 2 |
| AstraZeneca | 1 |
| Biotronik AG | 1 |
| Boston Scientific Corporation | 1 |
| Central Hospital, Nancy, France | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 24 |
| Cardiovascular Diseases | 7 |
| Coronary Artery Disease | 4 |
| Dyslipidemias | 4 |
| Hypercholesterolemia | 3 |
| Myocardial Ischemia | 3 |
| Peripheral Arterial Disease | 3 |
| Arterial Occlusive Diseases | 2 |
| Arteriosclerosis | 2 |
| Coronary Disease | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.